Document is current
Any future updates will be listed below
-
Authors
Kim, Haejung
Choi, Ji Soo https://orcid.org/0000-0003-1361-5269
Chi, Sang Ah
Ryu, Jai Min
Lee, Jeong Eon
Kim, Myoung Kyoung
Lee, Jeongmin
Ko, Eun Sook
Ko, Eun Young
Han, Boo-Kyung
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (NRF 2021R1A2C1094010)
Korean Breast Cancer Society (KBCSG-28)
- License Information
-
More Information
Article History
Received: 28 July 2024
Revised: 28 November 2024
Accepted: 1 January 2025
First Online: 25 March 2025
Compliance with ethical standards
:
: The scientific guarantor of this publication is Ji Soo Choi.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: One of the authors has significant statistical expertise.
: Written informed consent was waived for the retrospective development cohort by the Institutional Review Board. Written informed consent was obtained from the prospective validation cohort.
: Institutional Review Board approval was obtained.
: The ASLAN trial is a prospective, multicenter, single-arm surgical trial registered under the identifier NCT04993625. It is currently an ongoing study with a planned 5-year follow-up period. Among the patients enrolled at our institution in the ASLAN trial, 30 have been included in this study. However, as there are no published papers related to the ASLAN trial at this time, we confirm that there is no publication overlap.
:
